Academic Credentials
  • Ph.D., BIOMEDICAL SCIENCE, Drexel University, 2012
  • B.A., Chemistry and Biochemistry, LaSalle University, 2007
Licenses & Certifications
  • Certified Biological Safety Professional (CBSP)
  • Certified ISO 13485 Medical Device Management Systems Lead Auditor
  • ISO 10993-1:2018 - Biological evaluation of medical devices — Part 1: Evaluation and testing within a risk management process
  • ISO 14971:2019 - Application of risk management to medical devices
Academic Appointments
  • External Advisory Board (EAB), Temple University, Department of Bioengineering, 2018 - present
  • Adjunct Faculty, Drexel University, School of Biomedical Engineering, Science & Health Systems, 2016 - present
  • Lectures
  • Hazard Analysis During Design, School of Biomedical Engineering, Science and Health Systems, Drexel University Medical Device Development lecture, May 2024
  • Bioprinting, School of Biomedical Engineering, Science and Health Systems, Drexel University Biomedical Additive Manufacturing lecture, August 2023
  • Hazard Analysis During Design, School of Biomedical Engineering, Science and Health Systems, Drexel University Medical Device Development lecture, May 2023
  • Additive Manufacturing, Tissue Engineering, and Point-of-Care, School of Biomedical Engineering, Science and Health Systems, Drexel University Biomedical Additive Manufacturing lecture, November 2022
  • Hazard Analysis During Design, School of Biomedical Engineering, Science and Health Systems, Drexel University Medical Device Development lecture, May 2022
  • Additive Manufacturing and Regenerative Medicine, School of Biomedical Engineering, Science and Health Systems, Drexel University Biomaterials lecture, August 2021
  • A Career in Engineering and Scientific Consulting, School of Biomedical Engineering, Science and Health Systems, Drexel University Biomaterials lecture, November 2020
  • Additive Manufacturing and Tissue Engineering, School of Biomedical Engineering, Science and Health Systems, Drexel University Biomedical Additive Manufacturing lecture, August 2020.
  • Stem Cell Therapies for Tissue Engineering Applications: An FDA Update and Introduction to Regulatory Affairs School of Biomedical Engineering, Science and Health Systems, Drexel University Tissue Engineering lecture, March 2018
  • Stem Cell Therapies for Orthopedic Applications: Hard vs. Soft Tissues School of Biomedical Engineering, Science and Health Systems, Drexel University Tissue Engineering lecture, March 2017
Professional Honors
  • International Cartilage Repair Society Postdoctoral Travel Award
  • LaSalle University Founder's Scholarship
Professional Affiliations
  • ASTM Working Group F04
  • Society for Biomaterials
  • International Cartilage Regeneration & Joint Preservation Society
  • Standards Coordinating Body (Regenerative Medicine)

Dr. Frohbergh works closely with his clients from strategic planning and experimental design/testing through risk analysis and regulatory considerations. His expertise focuses on medical device biological safety, biocompatibility, risk and quality management, experimental design, and remediation management. 

Dr. Frohbergh's technical background is in regenerative medicine with a concentration in bone and cartilage, natural and synthetic biomaterials, in vivo biocompatibility and analysis of medical devices and implantable materials. He specializes in physical, chemical and mechanical characterization of biomimetic materials and tissue scaffolds and pre-clinical evaluation for tissue interaction and integration and performance. He also has extensive experience with 3D printing and additive manufacturing for biomedical applications and small animal models for wound healing, histology, cell and molecular biology techniques.

Dr. Frohbergh is a certified biological safety specialist and a certified ISO 13485 lead auditor. He supports his clients in quality and risk management of medical devices, including ISO 10993, ISO 14971, 21 CFR 820, 21 CFR 1271 and regulation EU 2017/745 (MDR). He also currently holds an adjunct professor position for the department of Biomedical Engineering, Science and Health Systems at Drexel University, where he has lectured on the regulatory issues and FDA framework related to stem cell therapies. He is also a member of the External Advisory Board (EAB) for the Department of Bioengineering at Temple University.

Prior to joining Exponent, Dr. Frohbergh earned his Ph.D. at Drexel University where his work focused on developing and characterizing an electrospun, crosslinked chitosan/hydroxyapatite scaffold for non-load bearing cranial bone regeneration, as well as its in vivo performance to induce wound healing. He then worked as a postdoctoral fellow at Icahn School of Medicine at Mount Sinai Hospital in the department of Genetics and Genomic Sciences where he evaluated articular cartilage repair using enzymatically treated cells in rodent models. While at Mount Sinai, he developed their rodent osteochondral defect model and protocol. He also worked on rare lysosomal storage disease mechanisms including mucopolysaccharidosis (MPS) and Farber disease. He was also involved in helping to develop the Mt. Sinai Institute of Technology (MSIT) and a mentor/assistant for the Design, Technology and Entrepreneurship (DTE) graduate classes.